Pyridine compounds
US8569298B2 · kind B2 · utility
5Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2009 |
| Grant date | Oct 29, 2013 |
| Priority date | — |
| Expiry date | Sep 16, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds that inhibit of focal adhesion kinase function, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment in warm-blooded animals such as humans of diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.